BlueWind Medical Receives FDA Approval for Pivotal Trial Desig...
HERZLIYA, Israel, June 15, 2018 /PRNewswire-AsiaNet/ -- BlueWind Medical, a developer of a miniature wireless neurostimulation platform, for the treatment of multiple clinical indications, announced today that the US Food and Drug Administration (FDA) has approved the company's pivotal study design for...